Wordt geladen...
JAK/STAT signaling in hepatocellular carcinoma
Liver cancer is the second most lethal cancer in the world with limited treatment options. Hepatocellular carcinoma (HCC), which accounts for more than 80% of all liver cancers, has had increasing global incidence over the past few years. There is an urgent need for novel and better therapeutic inte...
Bewaard in:
| Gepubliceerd in: | Hepat Oncol |
|---|---|
| Hoofdauteurs: | , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Future Medicine Ltd
2020
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7137178/ https://ncbi.nlm.nih.gov/pubmed/32273976 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/hep-2020-0001 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|